Resumen de: PL447926A1
Przedmiotem zgłoszenia jest sposób wytwarzania pożywki do hodowli sinic z biomasy bakteryjnej po produkcji polihydroksyalkanianów. Wynalazek znajduje zastosowanie w hodowli zwłaszcza Arthrospira platensis.
Resumen de: WO2025181256A1
The invention relates to modified cyanobacterial strains comprising one or more modifications to enhance the rate of carbon dioxide fixation relative to a cyanobacterial strain which does not comprise said modifications.
Resumen de: AU2024387147A1
The present invention relates to a glass noodles wastewater treatment process based on microalgae, belonging to the technical field of microbial wastewater treatment. Chlorella sorokiniana NZ1 and Monoraphidium sp. NZ4 are selected. An analysis of experiment results shows that when Chlorella sorokiniana NZ1 and Monoraphidium sp. NZ4 are subjected to mixed culturing, the biomass of both in the wastewater reaches the highest level. At the same time, the removal rates of water quality indicators also exhibit the most significant improvement; specifically, the removal rates of COD, TN, ammonia nitrogen, and TP can respectively reach 83.4%, 91.19%, 81.51%, and 78.71%. Thus, it can be concluded that subjecting the algal strains NZ1 and NZ4 to mixed culturing is the most effective glass noodles wastewater treatment method.
Resumen de: US2025277228A1
Monoclonal antibodies represent the most rapidly growing category of the recombinant therapeutic protein pipeline, with more than 85% of the therapeutic indications. The present invention proposes novel vectors that have been optimized so as to produce high levels of monoclonal antibodies when transfected in the microalgae Phaeodactylum tricornutum, as well as optimized culture conditions of said microalgae cells. Altogether, the present invention provides new systems for producing high amounts of monoclonal antibodies, functional fragments or derivatives thereof, in microalgae.
Resumen de: GB2638687A
A modified cyanobacterium comprising one or more genetic modifications for improving expression of aromatic amino acids through overexpression of shikimate pathway to enhance the rate of carbon dioxide fixation relative to a cyanobacterium which does not comprise said genetic modifications. Also disclosed is use of AroF D174N and/or TesA for increasing the rate of carbon dioxide fixation by a modified cyanobacterium. The cyanobacterium can be Synechococcus sp., e.g. Synechococcus 11901 or a variant thereof. The modified cyanobacterium can comprise one or more genetic modifications to over-express shikimate kinase (SK) in the modified cyanobacterium.
Resumen de: WO2024088808A1
Provided are compositions containing microalgae extracellular vesicles (MEVs) formulated for intranasal delivery, whereby, upon intranasal administration the MEVs traffic through specific routes following intranasal administration to specific regions in the brain via the olfactory nerve and throughout the lateral olfactory tract (LOT) to interconnected brain regions. The MEVs traffic via neuronal axonal transport. The MEVs have the ability to cross-over synapses including: (i) the synapses between the olfactory sensory neurons (OSN) and the mitral/tufted neurons; (ii) the synapses between the mitral/tufted neurons and the local neurons in the various brain regions colonized by the lateral olfactory tract (LOT); and (iii) the synapses between the neurons in the brain regions colonized by the LOT and neurons from the frontal cortex, the hippocampus, the thalamus, and the hypothalamus. The compositions contain extracellular vesicles from microalgae (MEVs) that are loaded with bioactive cargo for treating, detecting, diagnosing, or monitoring a disease, disorder, or condition of the brain or involving the brain, particularly providing neuronal delivery of the cargo. The compositions and methods have a variety of applications as therapeutics and diagnostics for treating, diagnosing, and monitoring a disease, disorder, or condition of the brain or involving the brain. The compositions can be used in methods and uses for treating cancers involving the brain, and can be used, for exa
Resumen de: US2025270486A1
An assembly, methods, and network for farming and culturing green microalgae (Haematococcus pluvialis) are disclosed, comprising: a mechanical support framework; a plurality of cultivation pouches, mechanically coupled to the mechanical support framework, having arrays of cultivation pouches where green microalgae (H. pluvialis) are cultured and harvested; a plurality of light emitting diodes (LEDs), mechanically coupled and supported by the mechanical support framework and arranged in between two of any adjacent arrays of cultivation pouches, operable to provide a predetermined light intensities to each of the cultivation pouches; and an air and gas supply and distribution unit, mechanically coupled and supported by the mechanical support framework, operable to supply predetermined amounts of air and carbon dioxide (CO2) to each of the green microalgae pouches.
Resumen de: WO2025176843A1
Provided are gene therapy vectors designated MEV-GTVs, which are MEVs that contain an ITR-containing plasmid (also referred to as a minigene plasmid) that comprises Inverted Terminal Repeats (ITRs), such as viral ITRs, and nucleic acid encoding a product of interest, and optionally regulatory sequences. The ITRs serve to circularize the minigene plasmid. The plasmids do not contain additional viral components, so that resulting DNA is not encapsulated in a viral capsid or envelop and is not replicated by viral genes. The plasmids can be inserted into bacterial plasmids for propagation.
Resumen de: US2025270148A1
A method for processing animal products, in particular products from poultry farming, includes: a) chemically treating by placing collected waste in contact with an ammonia-based buffer with a pH of at least 8; b) heating the material resulting from step a) in a humid medium to a temperature of at least 70° C.; c) separating the organic matter and inorganic matter in the presence of water from the material resulting from step b), then separated collection of (i) the liquid fraction having the inorganic matter, and (ii) the solid fraction having the organic matter; and d) adding the liquid fraction resulting from step c (ii), having the inorganic matter, in a basin filled with water held in a controlled manner at a setpoint temperature ranging from 20° C. to 42° C., preferably from 28° C. to 35° C., in which a protein-rich plant or bacterium is cultivated, in particular microalgae or cyanobacteria, preferably spirulina.
Resumen de: WO2025176847A1
Provided are compositions containing microalgae extracellular vesicles (MEVs) formulated for administration to the eye for treatment of diseases, disorders, and conditions of the eye, particularly for diseases, disorders, and conditions that involve tissues and cells in the back of the eye, which generally cannot be treated with eyedrops. Upon administration to the eye, the MEVs deliver therapeutics to tissues that include the choroid, retinal pigment epithelium cells, and photoreceptor cells. The compositions contain extracellular vesicles from microalgae (MEVs) that are loaded with bioactive cargo for treating or diagnosing or monitoring a disease, disorder, or condition of the eye or involving the eye. Methods of treatment of diseases, disorders, and conditions of the eye are provided.
Resumen de: KR20250127241A
미세조류에서 타겟 유효성분을 포함하는 엑소좀 추출 방법은 미세 조류를 광활성 배양하는 것, 광활성 배양된 미세 조류를 초음파 분쇄하여 세포 용해물을 생성하는 것, 및 세포 용해물로부터 엑소좀을 추출하는 것을 포함한다.
Resumen de: KR20250127240A
메디컬 조성물은 미세 조류를 광활성 배양하는 것, 광활성 배양된 미세 조류를 초음파 분쇄하여 세포 용해물을 생성하는 것, 및 세포 용해물로부터 엑소좀을 추출하는 것을 포함하는 엑소좀 추출 방법에 의해 획득된 엑소좀을 포함한다.
Resumen de: WO2025174210A1
The present invention relates to: a feed composition for zooplankton, comprising biomass derived from Schizochytrium sp. microalgae; a method for culturing zooplankton using same; and an aquaculture method for fish or crustaceans. The biomass derived from Schizochytrium sp. microalgae of the present invention has the effect of nutritionally enriching zooplankton, and when zooplankton fed with the biomass is fed to fish or crustaceans, growth of fish or crustaceans is promoted and non-specific immunity is enhanced, and thus the biomass can be effectively used as a feed composition or a feed additive.
Resumen de: WO2025174210A1
The present invention relates to: a feed composition for zooplankton, comprising biomass derived from Schizochytrium sp. microalgae; a method for culturing zooplankton using same; and an aquaculture method for fish or crustaceans. The biomass derived from Schizochytrium sp. microalgae of the present invention has the effect of nutritionally enriching zooplankton, and when zooplankton fed with the biomass is fed to fish or crustaceans, growth of fish or crustaceans is promoted and non-specific immunity is enhanced, and thus the biomass can be effectively used as a feed composition or a feed additive.
Resumen de: US2025266181A1
The present disclosure relates to an apparatus and method for treating high volumetric wastewater, containing tritium, and more particularly to an apparatus for treating wastewater, containing tritium, includes a container storing wastewater, containing tritium, an LED cable including an LED light source, a gas supply cable, and a transparent cover seating the container, wherein the gas supply cable is provided to supply air and carbon dioxide in a form of fine bubbles, and a method for treating wastewater, containing tritium, includes an operation of pouring wastewater, containing tritium, into a container of the apparatus for treating wastewater, containing tritium; an operation of injecting microalgae into the container; and an operation of inducing photosynthesis by using light of an LED cable under fine bubbles supplied by a gas supply cable.
Resumen de: KR20250123496A
본 발명은 미세조류 유래 유용물질을 포함하는 항염증 조성물에 관한 것으로, 구체적으로 미세조류 추출물을 포함하는 항염증 조성물, 상기 조성물을 포함하는 건강기능식품에 관한 것이다.
Resumen de: KR20250123503A
본 발명은 골질환의 개선, 예방 또는 치료용 조성물에 관한 것으로, 보다 상세하게는 미세조류 추출물을 유효성분으로 함유함으로써, 골질환을 개선, 예방 또는 치료할 수 있으므로, 식품 조성물, 나아가 건강기능식품 또는 약학 조성물로 활용될 수 있다.
Resumen de: KR20250122828A
본 발명은 차아염소산칼슘(calcium hypochlorite, Ca(ClO)2)을 이용한 미세조류 배양 배지의 화학적 멸균방법에 관한 것으로, 차아염소산칼슘(calcium hypochlorite, Ca(ClO)2)을 미세조류 배양 배지에 넣어 멸균한 후 MnCl2-Na2EDTA 복합체 및 glucose의 촉매 반응을 통해 차아염소산칼슘을 중화시켜 멸균된 미세조류 배양 배지에 의해 미세조류의 성장을 증대시키는 것이 특징이다. 상기 본 발명에 따른 미세조류 성장의 증대는 영양 보충제, 식품 착색제, 사료 첨가제 및 성장 촉진제, 폐수 처리제, 바이오 연료 등 다양한 산업 분야에 활용될 수 있다.
Resumen de: US2025257313A1
A culture device comprises: a gas supply unit; and a plurality of containers. The gas supply unit is connected with the plurality of containers through a plurality of gas supply lines, respectively. The plurality of gas supply lines are provided with a plurality of valves, respectively. While microalgae are cultured in the plurality of containers, the opening degrees of the plurality of valves are adjusted. By such adjustment of the opening degrees, a greater amount of gas is supplied to one of the plurality of containers than those of the other containers.
Resumen de: US2025257372A1
The subject invention provides compositions and methods for reducing deleterious atmospheric gases using microorganisms. In preferred embodiments, a composition comprising one or more beneficial microorganisms convert carbon dioxide to calcium carbonate, magnesium carbonate, a bicarbonate, or a combination thereof. The source of the carbon dioxide can be industrial emissions. In some embodiments, the composition sequesters carbon with the use of a trough growth system and the culture and/or growth by-product can be sequestered in underground geological formations.
Resumen de: WO2025166399A1
The present disclosure generally relates to liquid compositions that can be used to treat a water body, for example a dam, river or waste water. In particular, the present disclosure relates to compositions that can be used to control cyanobacteria in a water body. The liquid compositions comprise worm castings, a sugar source and optional other additives/excipients. The present disclosure also relates to methods of treating a water body using the liquid compositions. The present disclosure also relates to processes for preparing the liquid compositions, and also to uses and kits comprising the liquid compositions.
Resumen de: US2025255337A1
In alternative embodiments, provided are compositions, including products of manufacture, foods and drinks and kits, comprising one or mixtures of two or more or a plurality of microalgae, wherein the microalgae, optionally blue-green algae or cyanobacteria, or extracts of the microalgae, or dried extracts of the microalgae, are formulated into a food, candy, nutritional supplement, or an ingestible liquid. In alternative embodiments, the one or two or more or a plurality of microalgae comprise a microalgae from the genus: Spirulina sp., Arthrospira sp., Limnospira sp, Dunaliella salina, and/or Nannochloropsis salina. In alternative embodiments, the one or two or more or a plurality of microalgae are formulated into a food such as a guacamole (to generate for example, to generate a Microalgae-Enriched Guacamole (MEG).
Resumen de: AU2025203546A1
The present invention is directed to methods and materials for producing recombinant viruses. In particular, methods and materials are provided for producing recombinant viruses in eukaryotic microalgae such as Chlamydomonas reinhardtii. Recombinant adeno- associated viruses are examples of recombinant viruses produced according to the invention. The present invention is directed to methods and materials for producing recombinant viruses. In particular, methods and materials are provided for producing recombinant viruses in eukaryotic microalgae such as Chlamydomonas reinhardtii. Recombinant adeno- associated viruses are examples of recombinant viruses produced according to the invention. ay h e p r e s e n t i n v e n t i o n i s d i r e c t e d t o m e t h o d s a n d m a t e r i a l s f o r p r o d u c i n g r e c o m b i n a n t v i r u s e s n a y p a r t i c u l a r , m e t h o d s a n d m a t e r i a l s a r e p r o v i d e d f o r p r o d u c i n g r e c o m b i n a n t v i r u s e s i n e u k a r y o t i c m i c r o a l g a e s u c h a s h l a m y d o m o n a s r e i n h a r d t i i e c o m b i n a n t a d e n o - a s s o c i a t e d v i r u s e s a r e e x a m p l e s o f r e c o m b i n a n t v i r u s e s p r o d u c e d a c c o r d i n g t o t h e i n v e n t i o n
Resumen de: US2025250533A1
Provided is an alga belonging to Cyanidiophyceae having a diploid cell and a haploid cell form. Also provided is a nutrient composition containing an alga belonging to Cyanidiophyceae or an extract thereof.
Nº publicación: WO2025166275A1 07/08/2025
Solicitante:
UNIV OF WYOMING [US]
UNIVERSITY OF WYOMING
Resumen de: WO2025166275A1
Aspects of the present disclosure generally relate to a new class of compositions that include microalgae encapsulated within a polymerized hydrogel. Aspects of the present disclosure also generally relate to high density algal biomass and to new processes for growing algal biomass. In an aspect is provided a composition that includes an encapsulant comprising a polymerized hydrogel, and microalgae encapsulated within the encapsulant. In another aspect, a process for encapsulating algae is provided. The process includes: introducing, to a device, a stream of core fluid comprising microalgae and a hydrogel precursor; contacting the stream of core fluid with two streams of a focusing fluid to form a thinner stream of core fluid comprising the microalgae and the hydrogel precursors, the focusing fluid having a different viscosity than the core fluid; and exposing the thinner stream of the core fluid to UV light to form a composition described herein.